vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and FARMERS NATIONAL BANC CORP (FMNB). Click either name above to swap in a different company.
FARMERS NATIONAL BANC CORP is the larger business by last-quarter revenue ($71.5M vs $62.1M, roughly 1.2× Cytek Biosciences, Inc.). FARMERS NATIONAL BANC CORP runs the higher net margin — 20.5% vs -70.9%, a 91.4% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 3.2%). FARMERS NATIONAL BANC CORP produced more free cash flow last quarter ($52.2M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 6.2%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Farmers National Banc Corp (OH) is a regional financial holding company based in Ohio, the United States. It offers full-spectrum retail and commercial banking products, wealth management solutions, and insurance services, primarily catering to individual consumers, small and medium-sized enterprises, and local community clients in Ohio and adjacent Midwestern U.S. regions.
CTKB vs FMNB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $71.5M |
| Net Profit | $-44.1M | $14.6M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 24.8% |
| Net Margin | -70.9% | 20.5% |
| Revenue YoY | 8.1% | 3.2% |
| Net Profit YoY | -557.1% | 1.7% |
| EPS (diluted) | — | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $71.5M | ||
| Q3 25 | $52.3M | $70.8M | ||
| Q2 25 | $45.6M | $69.8M | ||
| Q1 25 | $41.5M | $67.8M | ||
| Q4 24 | $57.5M | $69.3M | ||
| Q3 24 | $51.5M | $70.3M | ||
| Q2 24 | $46.6M | $66.5M | ||
| Q1 24 | $44.9M | $63.4M |
| Q4 25 | $-44.1M | $14.6M | ||
| Q3 25 | $-5.5M | $12.5M | ||
| Q2 25 | $-5.6M | $13.9M | ||
| Q1 25 | $-11.4M | $13.6M | ||
| Q4 24 | $9.6M | $14.4M | ||
| Q3 24 | $941.0K | $8.5M | ||
| Q2 24 | $-10.4M | $11.8M | ||
| Q1 24 | $-6.2M | $11.2M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 24.8% | ||
| Q3 25 | -17.6% | 20.7% | ||
| Q2 25 | -23.3% | 23.4% | ||
| Q1 25 | -36.1% | 24.1% | ||
| Q4 24 | 5.2% | 25.5% | ||
| Q3 24 | -8.2% | 14.4% | ||
| Q2 24 | -18.3% | 21.3% | ||
| Q1 24 | -23.9% | 21.2% |
| Q4 25 | -70.9% | 20.5% | ||
| Q3 25 | -10.5% | 17.6% | ||
| Q2 25 | -12.2% | 19.9% | ||
| Q1 25 | -27.5% | 20.0% | ||
| Q4 24 | 16.8% | 20.8% | ||
| Q3 24 | 1.8% | 12.1% | ||
| Q2 24 | -22.4% | 17.7% | ||
| Q1 24 | -13.8% | 17.7% |
| Q4 25 | — | $0.39 | ||
| Q3 25 | — | $0.33 | ||
| Q2 25 | — | $0.37 | ||
| Q1 25 | — | $0.36 | ||
| Q4 24 | — | $0.38 | ||
| Q3 24 | — | $0.23 | ||
| Q2 24 | — | $0.31 | ||
| Q1 24 | — | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | $86.7M |
| Stockholders' EquityBook value | $341.7M | $485.7M |
| Total Assets | $461.5M | $5.2B |
| Debt / EquityLower = less leverage | — | 0.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
| Q4 25 | — | $86.7M | ||
| Q3 25 | — | $86.6M | ||
| Q2 25 | — | $86.4M | ||
| Q1 25 | — | $86.3M | ||
| Q4 24 | — | $86.2M | ||
| Q3 24 | — | $86.0M | ||
| Q2 24 | — | $88.9M | ||
| Q1 24 | — | $88.8M |
| Q4 25 | $341.7M | $485.7M | ||
| Q3 25 | $378.6M | $465.9M | ||
| Q2 25 | $377.6M | $437.7M | ||
| Q1 25 | $379.6M | $429.1M | ||
| Q4 24 | $395.7M | $406.0M | ||
| Q3 24 | $385.5M | $439.7M | ||
| Q2 24 | $389.1M | $396.7M | ||
| Q1 24 | $392.6M | $397.0M |
| Q4 25 | $461.5M | $5.2B | ||
| Q3 25 | $494.9M | $5.2B | ||
| Q2 25 | $493.3M | $5.2B | ||
| Q1 25 | $482.6M | $5.2B | ||
| Q4 24 | $499.5M | $5.1B | ||
| Q3 24 | $491.2M | $5.2B | ||
| Q2 24 | $483.7M | $5.2B | ||
| Q1 24 | $492.1M | $5.1B |
| Q4 25 | — | 0.18× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.20× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $60.0M |
| Free Cash FlowOCF − Capex | $-1.8M | $52.2M |
| FCF MarginFCF / Revenue | -2.9% | 73.0% |
| Capex IntensityCapex / Revenue | 1.6% | 11.0% |
| Cash ConversionOCF / Net Profit | — | 4.10× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $85.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $60.0M | ||
| Q3 25 | $-3.9M | $10.7M | ||
| Q2 25 | $108.0K | $14.0M | ||
| Q1 25 | $-125.0K | $15.7M | ||
| Q4 24 | $2.0M | $66.6M | ||
| Q3 24 | $13.2M | $23.9M | ||
| Q2 24 | $6.2M | $16.6M | ||
| Q1 24 | $4.0M | $13.7M |
| Q4 25 | $-1.8M | $52.2M | ||
| Q3 25 | $-4.6M | $9.0M | ||
| Q2 25 | $-1.5M | $12.4M | ||
| Q1 25 | $-974.0K | $12.2M | ||
| Q4 24 | $1.1M | $54.9M | ||
| Q3 24 | $12.2M | $20.4M | ||
| Q2 24 | $5.2M | $14.4M | ||
| Q1 24 | $3.4M | $12.2M |
| Q4 25 | -2.9% | 73.0% | ||
| Q3 25 | -8.7% | 12.8% | ||
| Q2 25 | -3.2% | 17.8% | ||
| Q1 25 | -2.3% | 18.0% | ||
| Q4 24 | 1.9% | 79.2% | ||
| Q3 24 | 23.7% | 29.1% | ||
| Q2 24 | 11.0% | 21.6% | ||
| Q1 24 | 7.6% | 19.2% |
| Q4 25 | 1.6% | 11.0% | ||
| Q3 25 | 1.3% | 2.4% | ||
| Q2 25 | 3.5% | 2.3% | ||
| Q1 25 | 2.0% | 5.2% | ||
| Q4 24 | 1.6% | 16.9% | ||
| Q3 24 | 2.0% | 4.9% | ||
| Q2 24 | 2.3% | 3.3% | ||
| Q1 24 | 1.3% | 2.4% |
| Q4 25 | — | 4.10× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 1.15× | ||
| Q4 24 | 0.21× | 4.63× | ||
| Q3 24 | 14.05× | 2.80× | ||
| Q2 24 | — | 1.41× | ||
| Q1 24 | — | 1.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
FMNB
Segment breakdown not available.
